More medicines vs cancer, diabetes now VAT-exempt

The Bureau of Internal Revenue (BIR) has approved an updated set of medicines that are exempted from the value-added tax (VAT) following the Food and Drug Administration’s (FDA) endorsement of additional drugs that will benefit patients battling serious and chronic illnesses. Under Revenue Memorandum Circular 108-2025, more than 2,000 medicines used for cancer, diabetes, high